Product Images Losartan Potassium
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 7 images provide visual information about the product associated with Losartan Potassium NDC 53808-0896 by State Of Florida Doh Central Pharmacy, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Label Image for 25mg - 25mg qualitest
Losartan potassium is a medication available in tablet form with a strength of 25mg. This is a prescription-only medication and the quantity provided is 30 tablets. It is manufactured by Qualitest and has the lot number 1205004315. The package of the medication was produced on 2nd December 2013 and expiry date of the medication is 31st August 2013. The medication was packaged by DOH Central Pharmacy located in Taliahassee, FL 32304. The provided UPC code is 306034224321.*
Label Image for 50mg - 50mg qualitest
Figure-1 - figure 1
This text is a combination of a medicine's name (Atenolol) and another medicine's name (Losartan Potassium Tablets), followed by a graph with a horizontal axis showing different study months and a vertical axis showing an adjusted risk reduction percentage of 13%. Without context it is difficult to say what the graph is representing.*
Figure-2 - figure 2
Figure-3 - figure 3
The text is describing subgroups and their respective stroke rates based on a study that evaluated the effectiveness of Losartan potassium tablets compared to Alenolol tablets. The subgroups analyzed include age range, gender, race, history of CVD, and presence of diabetes. The table shows the number of events, rates, hazard ratios, and confidence intervals for each subgroup. The results are adjusted for baseline Framingham risk score and level of slectrocardiographic ef ventricular hypertrophy. The text also clarifies that "Other" includes individuals of Asian, Hispanic, Pacific Islander, Native American, and European descent.*
Figure-4 - figure 4
This text describes a study on the effectiveness of Losartan Potassium Tablets in reducing the risk of an event in patients. The study found that 9% of patients experienced an event, and that the use of Losartan Potassium Tablets reduced the risk of an event by 16.1% compared to a placebo. The study was conducted over a period of 12, 24, 36, and 48 months.*
Structure-Losartan Potassium - structure
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.